Not found

Mauro Ferrari, PhD

Ernest Cockrell, Jr. Presidential Distinguished Chair, President & CEO, Research Institute
Director & Professor of Nanomedicine, Institute for Academic Medicine
Executive Vice President, Houston Methodist
Senior Associate Dean and Professor of Medicine, Weill Cornell Medical College
Houston Methodist
Weill Cornell Medical College


Research Lab


mferrari@houstonmethodist.org
Biography

Mauro Ferrari, PhD, is the Executive Vice President of Houston Methodist and the President and CEO of the Houston Methodist Research Institute where he is the Ernest Cockrell Jr. Presidential Distinguished Chair. As the Director of the Houston Methodist Institute for Academic Medicine, Ferrari oversees all research and education programs at Houston Methodist, over 1,200 research employees and credentialed clinicians executing more than 800 clinical protocols. He also serves as the Senior Associate Dean of the Weill Cornell Medical College, the primary academic affiliate of Houston Methodist and holds Adjunct and Honorary Professorships at many universities around the world.

Ferrari is the founder of biomedical nano/micro-technology, especially in their applications to drug delivery, cell transplantation, implantable bioreactors, and other innovative therapeutic modalities. Dr. Ferrari served as special expert on nanotechnology at the National Cancer Institute in 2003-2005, providing leadership for the formulation, refinement, and approval of the NCI's Alliance for Nanotechnology in Cancer, currently the world's largest program in medical nanotechnology.

He has to his credit more than 350 publications, including seven books and is the inventor of 30 issued patents in the US and Europe. Throughout his academic career, he has supervised trainees and students who have gone on to senior faculty positions at premier universities like Oxford, Massachusetts Institute of Technology (MIT), University of California Berkeley, University of California San Francisco, Duke University, University of Washington, and Ohio State University. Dr. Ferrari's degrees are in Mathematics (Padova, Italy), and Mechanical Engineering (M.S., & Ph.D., U.C. Berkeley).

His seminal contributions to the field of biomedical nanotechnology have been recognized through numerous awards and accolades, including: Founders Award - Controlled Release Society, the Wallace H. Coulter Award for Biomedical Innovation and Entrepreneurship, the ETH Zürich Stodola Medal, Blaise Pascal Medal in Biomedical Engineering - European Academy of Sciences, and the Shannon Director's Award of the National Institutes of Health. Dr. Ferrari is a Fellow of the American Society of Mechanical Engineers, American Academy for the Advancement of Science and American Institute for Medical and Biological Engineering. He also holds honorary doctorates in Electrical Engineering and Biotechnology from the University of Palermo and the University of Naples “Federico II”, respectively.

His career research and development portfolio totals over $50 million, including support from the NCI, NIH, DoD, NASA, NSF, DARPA, DoE, the state of Texas, the state of Ohio, the Ohio State University, and several private enterprises. He began his academic career at the University of California, Berkeley, where he tenured in Material Science, Civil Engineering, and Bioengineering. Upon recruitment to the Ohio State University, he served as the Edgar Hendrickson Professor of Biomedical Engineering, Professor of Internal Medicine, Mechanical Engineering and Materials Science. He was also the Associate Vice President, Health Sciences Technology and Commercialization, Associate Director of the Dorothy M. Davis Heart and Lung Research Institute and Director of the Biomedical Engineering Center. Upon recruitment to Houston, he served as professor and chair of the nanomedicine department at the University of Texas Health Science Center.

Description of Research

Nanomedicine for oncology, traumatic injury, cardiovascular disease, infectious pathologies, and diabetes
Nanofluidics
Biomedical Microtechnology (BioMEMS)
Drug delivery
Proteomics and peptidomics for early detection and therapeutic monitoring
Cell transplantation, regenerative medicine, and tissue engineering
Biosensors and bioseparation technology
Multiscale discrete/continuum mechanics and biomechanics
Bioethics

Areas Of Expertise

Nanomedicine Cancer Nanofluidics Drug delivery Biomedical microtechnology (BioMEMS)
Education & Training

, Universita' di Padova
, University of California Berkeley
Patents

MULTISTAGE DELIVERY OF ACTIVE AGENTS

Patent Number: US2016051481, Feb 25 2016


Porous structures with modified biodegradation kinetics

Patent Number: AU2009337181, Aug 04 2011

Publications

Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination
Persano, S, Guevara, ML, Li, Z, Mai, J, Ferrari, M, Pompa, PP & Shen, H 2017, Biomaterials, vol 125, pp. 81-89. DOI:

Post-nano strategies for drug delivery: multistage porous silicon microvectors
Venuta, A, Wolfram, J, Shen, H & Ferrari, M 2017, Journal of Materials Chemistry B, vol 5, no. 2, pp. 207-219. DOI:

Taking the vehicle out of drug delivery
Shen, J, Wolfram, J, Ferrari, M & Shen, H 2017, Materials Today. DOI:

From modeling to in vivo tracking: a new platform for the design of delivery vectors that exploit tumor microfluidics.
Nizzero, S, Litvinov, S, Alexeev, D, Economides, A, De Rosa, E, Wolfram, J, Koumoutsakos, P & Ferrari, M 2017, Cancer Research.

The active modulation of drug release by an ionic field effect transistor for an ultra-low power implantable nanofluidic system
Bruno, G, Canavese, G, Liu, X, Filgueira, CS, Sacco, A, Demarchi, D, Ferrari, M & Grattoni, A 2016, Nanoscale, vol 8, no. 44, pp. 18718-18725. DOI:

Enzyme-responsive multistage vector for drug delivery to tumor tissue
Mi, Y, Wolfram, J, Mu, C, Liu, X, Blanco, E, Shen, H & Ferrari, M 2016, Pharmacological Research, vol 113, pp. 92-99. DOI:

Strategies for improving drug delivery: nanocarriers and microenvironmental priming
Khalid, A, Persano, S, Shen, H, Zhao, Y, Blanco, E, Ferrari, M & Wolfram, J 2016, Expert Opinion on Drug Delivery, pp. 1-13. DOI:

Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability
Palomba, R, Parodi, A, Evangelopoulos, M, Acciardo, S, Corbo, C, de Rosa, E, Yazdi, IK, Scaria, S, Molinaro, R, Furman, NET, You, J, Ferrari, M, Salvatore, F & Tasciotti, E 2016, Scientific reports, vol 6, pp. 34422. DOI:

Label-Free Isothermal Amplification Assay for Specific and Highly Sensitive Colorimetric miRNA Detection
Persano, S, Guevara, ML, Wolfram, J, Blanco, E, Shen, H, Ferrari, M & Pompa, PP 2016, ACS omega, vol 1, no. 3, pp. 448-455. DOI:

Computational analysis of drug transport in tumor microenvironment as a critical compartment for nanotherapeutic pharmacokinetics
Ziemys, A, Klemm, S, Milosevic, M, Yokoi, K, Ferrari, M & Kojic, M 2016, Drug Delivery, vol 23, no. 7, pp. 2524-2531. DOI:

A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells
Scott, B, Shen, J, Nizzero, S, Boom, K, Persano, S, Mi, Y, Liu, X, Zhao, Y, Blanco, E, Shen, H, Ferrari, M & Wolfram, J 2016, Pharmacological Research, vol 111, pp. 413-421. DOI:

Computational analysis of drug transport in tumor microenvironment as a critical compartment for nanotherapeutic pharmacokinetics
Ziemys, A, Klemm, S, Milosevic, M, Yokoi, K, Ferrari, M & Kojic, M 2016, Drug Delivery, vol 23, no. 7, pp. 2524-2531. DOI:

Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism
Pownall, HJ , Rosales, C , Gillard, BK & Ferrari, M 2016, Houston Methodist DeBakey Cardiovascular Journal, vol 12, no. 3, pp. 146-150. DOI:

Mesenchymal stem cells from cortical bone demonstrate increased clonal incidence, potency, and developmental capacity compared to their bone marrow-derived counterparts
Blashki, D, Murphy, MB, Ferrari, M, Simmons, PJ & Tasciotti, E 2016, Journal of Tissue Engineering, vol 7, pp. 2041731416661196. DOI:

Hesperetin liposomes for cancer therapy
Wolfram, J, Scott, B, Boom, K, Shen, J, Borsoi, C, Suri, K, Grande, R, Fresta, M, Celia, C, Zhao, Y, Shen, H & Ferrari, M 2016, Current Drug Delivery, vol 13, no. 5, pp. 711-719.

Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions
Leonard, F, Curtis, LT, Yesantharao, P, Tanei, T, Alexander, JF, Wu, M, Lowengrub, J, Liu, X, Ferrari, M, Yokoi, K, Frieboes, HB & Godin, B 2016, Nanoscale, vol 8, no. 25, pp. 12544-12552. DOI:

A pyruvate decarboxylase-mediated therapeutic strategy for mimicking yeast metabolism in cancer cells
Scott, B, Shen, J, Nizzero, S, Boom, K, Persano, S, Mi, Y, Liu, X, Zhao, Y, Blanco, E, Shen, H, Ferrari, M & Wolfram, J 2016, Pharmacological Research.

The Emerging Role of Nanotechnology in Cell and Organ Transplantation
Tasciotti, E, Cabrera, FJ, Evangelopoulos, M, Martinez, JO, Thekkedath, UR, Kloc Stepkowska, M, Ghobrial, RM, Li, XC, Grattoni, A & Ferrari, M 2016, Transplantation. DOI:

Simulation of angiogenesis in a multiphase tumor growth model
Santagiuliana, R, Ferrari, M & Schrefler, BA 2016, Computer Methods in Applied Mechanics and Engineering, vol 304, pp. 197-216. DOI:

Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell Kill
Wang, Z, Kerketta, R, Chuang, YL, Dogra, P, Butner, JD, Brocato, TA, Day, A, Xu, R, Shen, H, Simbawa, E, AL-Fhaid, AS, Mahmoud, SR, Curley, SA, Ferrari, M, Koay, EJ & Cristini, V 2016, PLoS Computational Biology, vol 12, no. 6, e1004969. DOI: